{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":2,"items":[{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:33:09Z","timestamp":1790404389471,"version":"4.1.0"},"reference-count":31,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Hum Factors"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Suboptimal design of infusion pumps may lead to usage errors, thereby compromising patient safety. Usability evaluation enables medical device design teams to identify and rectify design-related usability issues in a timely manner. Nevertheless, existing research on infusion pump usability continues to exhibit limitations in aspects such as task design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The study aimed to evaluate the usability of an infusion pump (SLGO SP-200 [SLGO Medical Technology Co, Ltd]) through simulation-based testing with nurses in a usability laboratory designed to simulate an intensive care unit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 12 registered nurses with experience in using infusion pumps participated in this study. Nurses were asked to perform 12 operational tasks using the infusion pump. The participants were also asked to perform 7 knowledge tasks, where they were required to find relevant information in the user manual. Participants\u2019 behavioral measures (task completion time, frequency of manual query, frequency of asking for assistance from researchers, frequencies of operation difficulties, near-misses, and failures), perceptions (perceived ease of use, perceived concentration level required, perceived likelihood of making programming errors, perceived mental workload, satisfaction, and use intention) were collected to evaluate the usability and identify interface design deficiencies of the pump.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study found that the participants were generally able to complete the tasks. All operational tasks were completed within 3 minutes, and all knowledge tasks were completed within 2 minutes. Our study identified 79 difficult operations, 9 near-miss operations, and 36 operation failures. The causes of the above problems were analyzed. Participants generally found the infusion pump to be user-friendly, requiring a medium level of attention resources, and reported low levels of mental workload and likelihood of making programming errors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study results can provide a basis for the design of infusion pumps, help practitioners define the risks of use and the key content of training, and provide an important reference for the design of usability evaluation schemes for medical devices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/86443","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:40:06Z","timestamp":1773088806000},"page":"e86443","source":"Crossref","is-referenced-by-count":1,"title":["A Summative Usability Evaluation of an Infusion Pump Through Simulation-Based Testing With Nurses: Mixed Approach Study"],"prefix":"10.2196","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0641-790X","authenticated-orcid":false,"given":"Yingjun","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2863-7046","authenticated-orcid":false,"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9391-9056","authenticated-orcid":false,"given":"Yunlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3307-4810","authenticated-orcid":false,"given":"Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3993-1983","authenticated-orcid":false,"given":"Kaifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2025.1425409"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2004.011957"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/0310057x9302100533"},{"key":"ref4","unstructured":"White paper: Infusion pump improvement initiativeThe U.S. Food and Drug Administration20102026-02-18https:\/\/www.fda.gov\/medical-devices\/infusion-pumps\/white-paper-infusion-pump-improvement-initiative"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-8141(01)00060-9"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1518\/001872095779049435"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/154193120404801531"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2004.08.002"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2015-004465"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.displa.2024.102664"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocaf085"},{"key":"ref12","unstructured":"Infusion pump improvement initiativeFood and Drug Administration20172026-02-18https:\/\/www.fda.gov\/medical-devices\/infusion-pumps\/infusion-pump-improvement-initiative"},{"key":"ref13","unstructured":"Guidance on applying human factors and usability engineering to medical devices including drug-device combination products in great BritainMedicines and Healthcare products Regulatory Agency20212026-02-18https:\/\/assets.publishing.service.gov.uk\/media\/60521d98d3bf7f0455a6e61d\/Human-Factors_Medical-Devices_v2.0.pdf"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ergon.2020.102932"},{"key":"ref15","year":"2001","journal-title":"Human Factor Design Process for Medical Devices (ANSI\/AAMI HE74:2001)"},{"key":"ref16","year":"2007","journal-title":"Medical Devices - Application of Usability Engineering to Medical Devices"},{"key":"ref17","year":"2024","journal-title":"Guideline for Registration Review of Usability Engineering of Medical Devices"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/10447318.2014.930311"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/17483107.2024.2372310"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2024.2403700"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2019.07.011"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2009.032839"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2017.03.010"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2345\/0899-8205-54.4.258"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1201\/b19082","author":"Wiklund, ME","year":"2015","journal-title":"Usability Testing of Medical Devices"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/001872089203400407"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2004.11.008"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/2327857915041027"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1145\/191666.191729"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/s1553-7250(05)31026-9"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cnc.2018.02.004"}],"container-title":["JMIR Human Factors"],"language":"en","link":[{"URL":"https:\/\/humanfactors.jmir.org\/2026\/1\/e86443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:14:19Z","timestamp":1782839659000},"score":13.866938,"resource":{"primary":{"URL":"https:\/\/humanfactors.jmir.org\/2026\/1\/e86443"}},"issued":{"date-parts":[[2026,3,9]]},"references-count":31,"URL":"https:\/\/doi.org\/10.2196\/86443","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.86443","asserted-by":"object"}]},"ISSN":["2292-9495"],"issn-type":[{"value":"2292-9495","type":"electronic"}],"published":{"date-parts":[[2026,3,9]]}},{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:45:45Z","timestamp":1757702745061},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T00:00:00Z","timestamp":1391126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0086443","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T22:44:41Z","timestamp":1391208281000},"page":"e86443","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical Characteristics, Management, and Control of Permanent vs. Nonpermanent Atrial Fibrillation: Insights from the RealiseAF Survey"],"prefix":"10.1371","volume":"9","author":[{"given":"Jan","family":"Murin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Naditch-Br\u00fbl\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Brette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chern-En","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,1,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.amjmed.2005.10.057","article-title":"Quality of life in patients with atrial fibrillation: a systematic review","volume":"119","author":"G Thrall","year":"2006","journal-title":"Am J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"AS Go","year":"2001","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/heart.86.5.516","article-title":"Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew\/Paisley study","volume":"86","author":"S Stewart","year":"2001","journal-title":"Heart"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/europace\/eul097","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text","volume":"8","author":"V Fuster","year":"2006","journal-title":"Europace"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","article-title":"Rhythm or rate control in atrial fibrillation\u2013Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial","volume":"356","author":"SH Hohnloser","year":"2000","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"D Roy","year":"2008","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"IC Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"DG Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study","volume":"109","author":"SD Corley","year":"2004","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/eurheartj\/ehn139","article-title":"Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation","volume":"29","author":"R Nieuwlaat","year":"2008","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"R Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.03.034","article-title":"Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation)","volume":"58","author":"AJ Camm","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/heartjnl-2011-300550","article-title":"Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry","volume":"98","author":"PG Steg","year":"2012","journal-title":"Heart"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"AJ Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"IC Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"17B","DOI":"10.1016\/0002-9149(93)90035-B","article-title":"Rate-corrected QT interval: techniques and limitations","volume":"72","author":"C Funck-Brentano","year":"1993","journal-title":"Am J Cardiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/europace\/eun369","article-title":"The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management","volume":"11","author":"M Nabauer","year":"2009","journal-title":"Europace"},{"key":"ref18","first-page":"47","article-title":"Patients with atrial fibrillation in a primary care setting: Val-FAAP study","volume":"65","author":"V Barrios","year":"2012","journal-title":"Rev Esp Cardiol (Engl)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.acvd.2010.06.001","article-title":"Characteristics and management of outpatients with history of or current atrial fibrillation: the observational French EPHA study","volume":"103","author":"A Cohen","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejheart.2006.10.021","article-title":"Atrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry","volume":"9","author":"GM De Ferrari","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ahj.2004.09.053","article-title":"Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation","volume":"149","author":"CR Kerr","year":"2005","journal-title":"Am Heart J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.amjcard.2009.10.012","article-title":"The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation","volume":"105","author":"JY Le Heuzey","year":"2010","journal-title":"Am J Cardiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00392-008-0644-y","article-title":"AFFECT: a prospective, open-label, multicenter trial to evaluate the feasibility and safety of a short-term treatment with subcutaneous certoparin in patients with persistent non-valvular atrial fibrillation","volume":"97","author":"U Tebbe","year":"2008","journal-title":"Clin Res Cardiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.clinthera.2011.10.005","article-title":"One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis","volume":"33","author":"MH Kim","year":"2011","journal-title":"Clin Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2459\/JCM.0b013e32834f23e1","article-title":"Medical treatment of atrial fibrillation","volume":"13","author":"AJ Camm","year":"2012","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"SJ Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/eurheartj\/ehs348","article-title":"Editor\u2019s choice: Increased mortality among patients taking digoxin\u2013analysis from the AFFIRM study","volume":"34","author":"MG Whitbeck","year":"2013","journal-title":"Eur Heart J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/eurheartj\/eht120","article-title":"Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial","volume":"34","author":"M Gheorghiade","year":"2013","journal-title":"Eur Heart J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/europace\/euq006","article-title":"Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon","volume":"12","author":"M Ntep-Gweth","year":"2010","journal-title":"Europace"},{"key":"ref30","unstructured":"Atrial Fibrillation Progression Trial (ATTEST). Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01570361?term=attest&rank=2\" xlink:type=\"simple\">http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01570361?term=attest&amp;rank=2<\/ext-link>. Acessed 2013 October 22."}],"container-title":["PLoS ONE"],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0086443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:16:14Z","timestamp":1589037374000},"score":13.473219,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0086443"}},"editor":[{"given":"Wolfgang Rudolf","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"issued":{"date-parts":[[2014,1,31]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0086443","ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"published":{"date-parts":[[2014,1,31]]}}],"items-per-page":10,"query":{"start-index":0,"search-terms":null}}}